(37), we calculated a cytolytic activity score (mean PRF1 and GZMA expression) for each tumor sample and assessed its correlation with CD3+, CD79a+, CD204+, and FoxP3+ cell density as determined by IHC. The gene discussed is FOXP3; the disease is neoplasm.